Aspirin triggered lipid mediators (ATLMs) are disclosed which are useful for the treatment of prevention of inflammation associated with various diseases, including ischemia.

 
Web www.patentalert.com

< Substituted pyrroline kinase inhibitors

< Ketone compounds and compositions for cholesterol management and related uses

> 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same

> Treatment of conditions through modulation of the autonomic nervous system
~ 00603